Article
Posttransplant cyclophosphamide in unrelated and related peripheral blood stem cell transplantation from HLA-matched and 1 allele mismatched donor.
Bone marrow transplantation - 1 Mar 2024
Sugita Junichi, Kuroha Takashi, Ishikawa Jun, Eto Tetsuya, Fukushima Kentaro, Yokota Isao, Akashi Koichi, Taniguchi Shuichi, Harada Mine, Teshima Takanori
Abstract excerpt
Posttransplant cyclophosphamide (PTCy)-based graft-versus-host disease (GVHD) prophylaxis has been increasingly used in HLA-haploidentical transplantation and recent studies also demonstrated the efficacy of PTCy in HLA-matched transplantation. We conducted a prospective multicenter phase II study to evaluate the safety and efficacy of PTCy with tacrolimus and mycophenolate mofetil in 43 patients who underwent...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
